Growing community of inventors

Athens, GA, United States of America

Elliot Altman

Average Co-Inventor Count = 1.62

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 188

Elliot AltmanNeil M Bodie (7 patents)Elliot AltmanMark Andrew Eiteman (6 patents)Elliot AltmanYing Gao (2 patents)Elliot AltmanRavi R Gokarn (1 patent)Elliot AltmanHyo Park (1 patent)Elliot AltmanAnthony Farone (1 patent)Elliot AltmanShannon Smith (1 patent)Elliot AltmanStephen Wright (1 patent)Elliot AltmanJennifer R Walker (1 patent)Elliot AltmanKaren Maynard (1 patent)Elliot AltmanRenee Bodie (0 patent)Elliot AltmanRenee Bodie (1 patent)Elliot AltmanElliot Altman (24 patents)Neil M BodieNeil M Bodie (8 patents)Mark Andrew EitemanMark Andrew Eiteman (10 patents)Ying GaoYing Gao (2 patents)Ravi R GokarnRavi R Gokarn (31 patents)Hyo ParkHyo Park (2 patents)Anthony FaroneAnthony Farone (2 patents)Shannon SmithShannon Smith (1 patent)Stephen WrightStephen Wright (1 patent)Jennifer R WalkerJennifer R Walker (1 patent)Karen MaynardKaren Maynard (1 patent)Renee BodieRenee Bodie (0 patent)Renee BodieRenee Bodie (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Georgia Research Foundation, Inc. (12 from 843 patents)

2. Trinity Therapeutics, Inc. (6 from 7 patents)

3. Middle Tennessee State University (3 from 6 patents)

4. Peptide Biosciences, Inc. (2 from 2 patents)

5. Zolaris Biosciences, LLC (1 from 1 patent)


24 patents:

1. 11980648 - Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirus

2. 11007169 - Cis-gnetin H and trans-gnetin H as therapeutic agents

3. 10993920 - 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic

4. 10179803 - Methods for inhibiting immune complex formation in a subject

5. 10018618 - Stabilizied bioactive peptides and methods of identification, synthesis and use

6. 9447145 - Compositions for inhibiting immune complex formation in a subject

7. 9322829 - Stabilized bioactive peptides and methods of identification, synthesis, and use

8. 9212346 - Substrate-selective co-fermentation process

9. 8652825 - Microbial production of pyruvate and other metabolites

10. 8551758 - Substrate-selective co-fermentation process

11. 8440201 - Stabilized bioactive peptides and methods of identification, synthesis, and use

12. 8362202 - Methods for inhibiting immune complex formation in a subject

13. 8278076 - Microbial production of pyruvate and pyruvate derivatives

14. 8030464 - Stabilized bioactive peptides and methods of identification, synthesis, and use

15. 7786258 - Methods for inhibiting immune complex formation in a subject

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…